Approximately 4–7 days following viral or tracer muscle injection, pups were perfused first with 1xPBS, then followed by 4% paraformaldehyde (PFA,
P6148 Sigma Aldrich). A ventral laminectomy was performed and the tissue was fixed overnight in 4% PFA at 4C. Spinal cords were removed from the vertebrate column and lumbar or thoracic level spinal cords were embedded in 4% low melting point agarose (
LMP agarose, 16520–100 Invitrogen) and 80–100 μm transverse slices were cut using a Leica
VT1000 vibratome. Vibratome slices were incubated, free-floating, with primary antibodies in 1xPBS, 1 % BSA and 0.3% Triton-X for 48 hr at 4C, washed three times with 1xPBS, and incubated for 24 hr with the appropriate secondary antibodies. Primary antibodies and working dilutions were: guinea pig anti-vGluT1 (1705:1:16,000; 1706:1:32,000; 1707:1:128,000 all this study),
rabbit anti-dsRed (1:1,000, Clontech),
goat anti-ChAT (1:200, Millipore),
chicken anti-GFP (1:4,000, Abcam),
rabbit anti-GFP (1:4,000, Invitrogen),
sheep anti-GFP (1:4,000, AbD Serotec), goat anti-CT-B (1:8,000, List Biologicals), and
mouse anti-CT-B (1:500, Abcam). Secondary antibodies used were all raised in donkey and conjugated to
FITC (1:1,000),
Cy3 (1:1,000), Cy5 (1:500), or
Alexa Fluor 488 – conjugated (1:1,000) (Jackson Immunoresearch Laboratories).
Balaskas N., Abbott L.F., Jessell T.M, & Ng D. (2019). Positional Strategies for Connection Specificity and Synaptic Organization in Spinal Sensory-Motor Circuits. Neuron, 102(6), 1143-1156.e4.